|
|
 |
|
Viewing report
|
|
|
|
Boston Scientific Corp. Sep 11
Standard & Poors, Sep 2011
Abstract
Large, global, diversified manufacturer of market-leading, minimally invasive medical devices; Extensive patent portfolio and high barriers to entry; and Expected stable operating cash flow in the next few years. Highly litigious industry; Highly competitive technology markets driven by constant product evolution and upgrades; Material investment required to maintain leadership position; Increasing regulatory scrutiny; and Pricing pressures from cost-containment efforts in the global health care system, especially for existing technologies. The ratings on Natick, Mass.-based Boston Scientific Corp. reflect Standard & Poor's Ratings Services' expectations that the company's leading market positions and diversity will continue to provide balance to its business, offsetting current difficulties in certain key product lines. We characterize the company's business risk profile as satisfactory. Despite declining debt...
Companies mentioned in this report are: Boston Scientific Corp.
Action: Review
Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.
Research Type: Full Analysis
|
|
|
|
